NASDAQ: CRME TSX: COM VANCOUVER, Sept. 2 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has earned a US$30 million milestone payment from its collaboration with Merck (known as MSD outside the United States and Canada), through an affiliate. The milestone was triggered by the recently announced marketing approval for BRINAVESS(TM) (vernakalant …
Source:Cardiome Achieves $30 Million Milestone
Posted under Affiliate Marketing
This post was written by on September 3, 2010
